‘A New Kind Of Future’? FDA’s Shuren Questions Whether Engagement With Industry Will Change Post-Pandemic
Device center chief reiterates during AdvaMed podcast that pre-sub meetings for many products won’t happen until 2022
Executive Summary
US FDA device center director Jeff Shuren is asking whether the agency’s engagement with industry has been changed forever because of COVID-19.